4/16
09:23 am
nvno
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024 [Yahoo! Finance]
Low
Report
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024 [Yahoo! Finance]
4/16
09:00 am
nvno
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
Low
Report
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
4/9
09:00 am
nvno
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer [Yahoo! Finance]
Low
Report
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer [Yahoo! Finance]
4/9
08:45 am
nvno
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer
Low
Report
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer
3/15
09:17 am
nvno
enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity [Yahoo! Finance]
Low
Report
enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity [Yahoo! Finance]
3/15
09:00 am
nvno
enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity
Low
Report
enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity
3/6
06:13 pm
nvno
enVVeno: The Road To Approval Seems Open From Here On [Seeking Alpha]
Medium
Report
enVVeno: The Road To Approval Seems Open From Here On [Seeking Alpha]
3/6
08:58 am
nvno
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting [Yahoo! Finance]
High
Report
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting [Yahoo! Finance]
3/6
08:40 am
nvno
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
High
Report
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
2/29
04:26 pm
nvno
enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
2/29
04:15 pm
nvno
enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Medium
Report
enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
2/20
08:52 am
nvno
Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024 [Yahoo! Finance]
Medium
Report
Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024 [Yahoo! Finance]
2/20
08:30 am
nvno
Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024
Medium
Report
Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024